Check-Cap
Total Raised
$22.13MInvestors Count
6Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Check-Cap has raised $22.13M over 6 rounds.
Check-Cap's latest funding round was a IPO for $18M on February 19, 2015.
Check-Cap's latest post-money valuation is from February 2015.
Sign up for a free demo to see Check-Cap's valuations in February 2015 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/19/2015 | IPO | $18M | 1 | |||
10/21/2014 | Corporate Minority | |||||
6/20/2012 | Grant | |||||
2/1/2012 | Unattributed | |||||
3/24/2011 | Unattributed VC |
Date | 2/19/2015 | 10/21/2014 | 6/20/2012 | 2/1/2012 | 3/24/2011 |
|---|---|---|---|---|---|
Round | IPO | Corporate Minority | Grant | Unattributed | Unattributed VC |
Amount | $18M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Check-Cap Deal Terms
1 Deal Term
Check-Cap's deal structure is available for 1 funding round, including their IPO from February 19, 2015.
Round | IPO |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO |
Check-Cap Investors
6 Investors
Check-Cap has 6 investors. Fosun Pharmaceutical invested in Check-Cap's Corporate Minority funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/21/2014 | 10/21/2014 | 1 Corporate Minority | Corporation | China | ||
Government | Israel | |||||
Diversified Financial Services | Connecticut | |||||
Corporation | Illinois | |||||
Corporate Venture | California |
First funding | 10/21/2014 | ||||
|---|---|---|---|---|---|
Last Funding | 10/21/2014 | ||||
Investor | |||||
Rounds | 1 Corporate Minority | ||||
Board Seats | |||||
Type | Corporation | Government | Diversified Financial Services | Corporation | Corporate Venture |
Location | China | Israel | Connecticut | Illinois | California |
Check-Cap Acquisitions
2 Acquisitions
Check-Cap acquired 2 companies. Their latest acquisition was MBody AI on September 11, 2025.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/11/2025 | Other Venture Capital | MBody AI | $0.11M | Acq - Pending | 4 | |
3/25/2024 | Other |
Date | 9/11/2025 | 3/25/2024 |
|---|---|---|
Investment Stage | Other Venture Capital | Other |
Companies | MBody AI | |
Valuation | ||
Total Funding | $0.11M | |
Note | Acq - Pending | |
Sources | 4 |
Compare Check-Cap to Competitors
Full-Life engages in radiopharmaceutical solutions. It initiates research, development, production, and commercialization of radiopharmaceuticals. It operates in the pharmaceutical sector. It was founded in 2021 and is based in Pudong, China.
Empyrean Medical Systems specializes in cancer treatment within the healthcare sector. The company offers a range of products across three core divisions: research and clinical devices, therapeutics, and informatics. These products utilize advancements in quantum physics, molecular biology, chemistry, and machine learning to improve the accuracy and safety of cancer treatment and research. It was founded in 2020 and is based in Boca Raton, Florida.
Monteris Medical specializes in minimally invasive neurosurgical technology within the healthcare sector. The company offers the NeuroBlate System, a robotically controlled laser thermal therapy that utilizes MRI-guided laser light to ablate unwanted brain tissue. Monteris primarily serves the healthcare industry, focusing on brain tumor treatment, radiation necrosis, and drug-resistant epilepsy. It was founded in 1999 and is based in Hopkins, Minnesota.
Radiation Shield Technologies focuses on the research, manufacturing, and production of personal protection systems for ionizing and nuclear radiation within the safety equipment industry. The company's primary offerings include a range of products made from their proprietary Demron fabric, which is designed to protect against radiation while allowing for movement. These products are used by first responders and military personnel during radiological and nuclear emergencies. It is based in Coral Gables, Florida.
HyperMed Imaging focuses on medical hyperspectral imaging technology for surface tissue oximetry within the healthcare sector. The company provides diagnostic imaging devices that measure the levels of oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in superficial tissue for various healthcare applications. HyperMed's products are used in clinical settings to assess tissue health. It was founded in 1997 and is based in Memphis, Tennessee.
Calypso Medical provides technologies in the radiation oncology market
Loading...